Inventor · disambiguated record
Leslie B. Gordon
Also filed as: GORDON LESLIE · GORDON LESLIE B
14 granted patents·6 pending applications·23 citations·filing 2004–2024
89Inventor score
Files withGORDON LESLIE B6US HEALTH5SAREPTA THERAPEUTICS INC4GOVERNMENT OF THE US SECRETARY OF THE DEPT OF2THE PROGERIA RES FOUNDATION2
Top patents by PatentIndex Score
20 records- 0189US7838531B2Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosisUS HEALTH·Filed 2007·Granted Nov 23, 2010·6 cites·11 claims
- 0288US8828356B2Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosisUS HEALTH·Filed 2013·Granted Sep 9, 2014·6 cites·14 claims
- 0384US10822608B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2017·Granted Nov 3, 2020·2 cites·4 claims
- 0479US9381203B2Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosisGORDON LESLIE B·Filed 2014·Granted Jul 5, 2016·4 cites·7 claims
- 0579US7297492B2LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosisUS HEALTH·Filed 2004·Granted Nov 20, 2007·5 cites·9 claims
- 0670US9115400B2LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosisUS HEALTH·Filed 2013·Granted Aug 25, 2015·0 cites·6 claims
- 0768US2015018381A1Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosisGOVERNMENT OF THE US SECRETARY OF THE DEPT OF·Filed 2014·Application pending·0 cites
- 0867US11802283B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2020·Granted Oct 31, 2023·0 cites·4 claims
- 0965US8034557B2LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosisUS HEALTH·Filed 2007·Granted Oct 11, 2011·0 cites·7 claims
- 1065US2024255529A1Novel assay and novel methods of treating aging-related conditionsTHE PROGERIA RES FOUNDATION·Filed 2024·Application pending·0 cites
- 1164US11857541B2Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosisGORDON LESLIE B·Filed 2020·Granted Jan 2, 2024·0 cites·7 claims
- 1264US10398721B2Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·0 cites·19 claims
- 1362US2024218365A1Formulation of an antisense oligomer conjugateSAREPTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1459US2019046508A1Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosisGORDON LESLIE B·Filed 2018·Application pending·0 cites
- 1558US10098871B2Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosisGORDON LESLIE B·Filed 2016·Granted Oct 16, 2018·0 cites·6 claims
- 1657US8691501B2Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosisGORDON LESLIE B·Filed 2012·Granted Apr 8, 2014·0 cites·4 claims
- 1757US2016002307A1Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosisGOVERNMENT OF THE US SECRETARY OF THE DEPT OF·Filed 2015·Application pending·0 cites
- 1853US8257915B2Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosisGORDON LESLIE B·Filed 2010·Granted Sep 4, 2012·0 cites·8 claims
- 1952US8535884B2LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosisERIKSSON B MARIA H·Filed 2011·Granted Sep 17, 2013·0 cites·4 claims
- 2049US2025060373A1Novel assay and novel methods of treating hutchinson-gilford progeria syndromeTHE PROGERIA RES FOUNDATION·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leslie B. Gordon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →